Cost-effectiveness analysis of oxaliplatin/5-FU/LV in adjuvant treatment of stage III colon cancer in the UK

Cost-effectiveness analysis of oxaliplatin/5-FU/LV in adjuvant treatment of stage III colon cancer in the UK

2005 ECCO 13: The European Cancer Conference, October 30 - November 3, 2005, Paris, France

Aballea, S. | Chancellor, J. | Raikou, M. | Drummond, M. | Jourdan, S. | Carita, P. | Bridgewater, J. | Boler, A. | Volume: , Issue: , Pages: , colon cancer, cost-effectiveness analysis,